Status:
TERMINATED
Medical Device Based on Polarized Light for Cutaneous Lesions Visualization
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Skin Lesion
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Skin cancers represent a real public health issue. The diagnosis of pre-cancerous lesions thus is a priority. The diagnosis gold standard is based on the combination of clinical and histopathological ...
Eligibility Criteria
Inclusion
- adult patient with a skin tumor (benign or cancerous) which has to be excised and analysed according to histopathological examination
- skin lesion belonging to one of these groups (diagnosed by clinical examination):
- cutaneous cyst
- seborrhoeic keratosis
- cutaneous carcinoma
- naevus
- melanoma
- actinic keratosis and cutaneous horn
- other skin tumors
- skin lesion size equal to or less than 5 cm
- signed written consent form
- patient affiliated to a social insurance
Exclusion
- skin lesion size strictly over than 5 cm
- eyelid lesion
- aluminium, POM (polyoxymethylene) or organic glass allergy
- known pregnancy, breast-feeding
Key Trial Info
Start Date :
June 19 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 14 2024
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT03796871
Start Date
June 19 2019
End Date
January 14 2024
Last Update
August 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpitaux Universitaires de Strasbourg
Strasbourg, France, 67091